KAYA — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Upheal is an AI-native electronic health record (EHR) platform for therapists that generates clinical progress notes from sessions and includes scheduling, billing, telehealth, and compliance tools.
AI & Machine LearningDigital HealthMental HealthNew York, US
Juraj Chrappa(Founder)inKarolina Mrozkova(Director)Martin Horvath(Founder)
Board seatTomas Pacinda· per SEC Form D
Co-investorsCalm/Storm VCCredo VenturesHeadlineInovia CapitalKaya Ventures
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in
BoardVishal Gulati(Director)Joel Schoppig(Director)
Co-investorsCivilization Ventures Management, LlcRecode VenturesTraun VenturesY CombinatorZAKA VCAmino Collective+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.













